Stephen B. Solomon

Dr. Stephen B. Solomon


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in American Journal of Roentgenology
Verified
Journal Article
Closed access
ADAjita Deodhar
Ajita Deodhar
TDTimm Dickfeld
Timm Dickfeld
GSGordon W. Single
Gordon W. Single
WHWilliam C. Hamilton
William C. Hamilton
RTRaymond H. Thornton
Raymond H. Thornton
SSStephen B. Solomon
Stephen B. Solomon
OBJECTIVE. Irreversible electroporation is a nonthermal ablative tool that uses direct electrical pulses to create irreversible membrane pores and cell death. The ablation zone is surrounded by a z...

1 December 2021 in Radiology
Verified
Journal Article
Closed access
Robbert S. PuijkRobbert S. Puijk
Robbert S. Puijk
MAMuneeb Ahmed
Muneeb Ahmed
AAAndreas Adam
Andreas Adam
YAYasuaki Arai
Yasuaki Arai
RARonald Arellano
Ronald Arellano
Martijn Ruben MeijerinkMartijn Ruben Meijerink
Martijn Ruben Meijerink
A panel of experts reached consensus on recommendations on when to assess oncologic outcomes per patient, per session, and per tumor; definitions of starting and ending times; definitions of surviv... There is currently no consensus regarding preferred clinical outcome measures following image-guided tumor ablation or clear definitions of oncologic end points. This consensus document proposes st...

15 March 2024 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
AGAnne V. Gonzalez
Anne V. Gonzalez
GSGerard A. Silvestri
Gerard A. Silvestri
DKDaniel Korevaar
Daniel Korevaar
YGYaron B. Gesthalter
Yaron B. Gesthalter
NANisha D. Almeida
Nisha D. Almeida
LYLonny B. Yarmus
Lonny B. Yarmus
Background: Advanced diagnostic bronchoscopy targeting the lung periphery has developed at an accelerated pace over the last two decades, whereas evidence to support introduction of innovative technologies has been variable and deficient. A major gap relates to variable reporting of diagnostic yield, in addition to limited comparative studies. Objectives: To develop a research framework to standardize the evaluation of advanced diagnostic bronchoscopy techniques for peripheral lung lesions. Specifically, we aimed for consensus on a robust definition of diagnostic yield, and we propose potential study designs at various stages of technology development. Methods: Panel members were selected for their diverse expertise. Workgroup meetings were conducted in virtual or hybrid format. The cochairs subsequently developed summary statements, with voting proceeding according to a modified Delphi process. The statement was cosponsored by the American Thoracic Society and the American College of Chest Physicians. Results: Consensus was reached on 15 statements on the definition of diagnostic outcomes and study designs. A strict definition of diagnostic yield should be used, and studies should be reported according to the STARD (Standards for Reporting Diagnostic Accuracy Studies) guidelines. Clinical or radiographic follow-up may be incorporated into the reference standard definition but should not be used to calculate diagnostic yield from the procedural encounter. Methodologically robust comparative studies, with incorporation of patient-reported outcomes, are needed to adequately assess and validate minimally invasive diagnostic technologies targeting the lung periphery. Conclusions: This American Thoracic Society/American College of Chest Physicians statement aims to provide a research framework that allows greater standardization of device validation efforts through clearly defined diagnostic outcomes and robust study designs. High-quality studies, both industry and publicly funded, can support subsequent health economic analyses and guide implementation decisions in various healthcare settings.

1 October 2005 in Radiology
Verified
Journal Article
Closed access
MAMohamad E. Allaf
Mohamad E. Allaf
IVIoannis M. Varkarakis
Ioannis M. Varkarakis
SBSam B. Bhayani
Sam B. Bhayani
TITakeshi Inagaki
Takeshi Inagaki
LKLouis R. Kavoussi
Louis R. Kavoussi
SSStephen B. Solomon
Stephen B. Solomon
PURPOSE: To retrospectively compare the pain control requirements of patients undergoing computed tomography (CT)-guided percutaneous radiofrequency (RF) ablation with those of patients undergoing CT-guided percutaneous cryoablation of small (≤4-cm) renal tumors. MATERIALS AND METHODS: The study was HIPAA compliant and received institutional review board exemption; informed consent was not required. Medical and procedure records of patients who underwent RF ablation and cryoablation of renal tumors from June 19, 2003, to February 28, 2004, were retrospectively reviewed for clinical data, tumor characteristics, and anesthesia information. During the study period, 10 men (mean age, 66.5 years) underwent cryoablation of 11 renal lesions, and 14 patients (11 men, four women; mean age, 68.1 years) underwent RF ablation of 15 renal tumors. Analgesic and sedative requirements during the procedure were compared. Standard anesthesia consisted of 5 mL of 1% lidocaine injected locally, and conscious sedation consist...

1 July 2013 in Radiology
Verified
Journal Article
Closed access
ERE. Ronan Ryan
E. Ronan Ryan
CSConstantinos T. Sofocleous
Constantinos T. Sofocleous
HSHeiko Schöder
Heiko Schöder
JCJorge A. Carrasquillo
Jorge A. Carrasquillo
SNSadek Nehmeh
Sadek Nehmeh
SSStephen B. Solomon
Stephen B. Solomon
The use of a split-dose technique for percutaneous ablation with fluorine 18 fluorodeoxyglucose (FDG) PET guidance facilitates targeting of FDG-avid lesions and may provide confirmation of treatment effectiveness. PurposeTo describe a split-dose technique for fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT)-guided ablation that permits both target localization and evaluation of treatment effectiveness.Materials and MethodsInstitutional review board approved the study with a waiver of consent. From July to December 2011, 23 patients (13 women, 10 men; mean age, 59 years; range, 35–87 years) with 29 FDG-avid tumors (median size, 1.4 cm; range, 0.6–4.4 cm) were targeted for ablation. The location of the lesion was the liver (n = 23), lung (n = 4), adrenal gland (n = 1), and thigh (n = 1). Radiofrequency ablation was performed in 17 lesions; microwave ablation, in six; irreversible electroporation, in five; and cryoablation, in one. The pathologic condition of the tumor was metastatic colorectal adenocarcinoma in 18 lesions, primary hepatocellular carcinoma in one lesion, and a variety of metastatic tumors in the remaining 10 lesions. A total of 4 mCi (148 MBq) of FDG was...

1 March 2011 in Urology
Verified
Journal Article
Closed access
ADAjita Deodhar
Ajita Deodhar
SMSébastien Monette
Sébastien Monette
GSGordon W. Single
Gordon W. Single
WHWilliam C. Hamilton
William C. Hamilton
RTRaymond Thornton
Raymond Thornton
SSStephen B. Solomon
Stephen B. Solomon